Partner Stephanie Sharron will serve on the upcoming panel, "Leveraging AI in Drug Discovery - Opportunities and Challenges" during the 24th annual conference of the Chinese American Biopharmaceutical Society on October 28.
This conference intends to bring scientists, executives and other biopharmaceutical professionals from the Pacific Rim countries together to discuss the latest advances in the biotechnology/pharmaceutical world, the unprecedented challenges and promises facing the industry, and the breathtaking developments and opportunities in Asia/Pacific countries.
